TetraLogic Pharmaceuticals
IPO- Employees
- 11–50
- Business Model
- B2B
- Total Funding
- $75.3M
- Last Round
- $6.0M Extension RoundSep 2010
- Rounds
- 6
About
Novel targeted cancer drugs
Summary
TetraLogic Pharmaceuticals is a Biotech company. It has raised $75.3M in total across 6 rounds, most recently a $6.0M Extension Round round in Sep 2010.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2010
Sign up to see all 6 rounds
Extension Round — per-round amounts, valuations, and who invested in each round.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tetralogic-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/tetralogic-pharmaceuticals" alt="TetraLogic Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>